The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.

Mary Louise Kelly is a co-host of All Things Considered, NPR's award-winning afternoon newsmagazine. Previously, she spent a decade as national security correspondent for NPR News, and she's kept ...

XAVIER BECERRA: Thanks, Mary Louise. KELLY: So I mentioned Wegovy ... These are drugs that, in a given year, will cost Medicare somewhere around $40 billion - just these 15.